← BackQHSLab, Inc. · Surgical & Medical Instruments & ApparatusUSAQ
Moderate riskNext report: Not enough history
The short versionA company still losing money with growing sales.
Going well
- Sales up 40% in the latest quarter vs a year ago
- Sales up 26% last year
- Little debt
Watch out for
- Share count growing 29.1% a year (dilution)
- Losing money
Money moves
- No insider buying or selling in the last 30 days
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$847K+40% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $3.0M, up 25% from the 12 months before. Over 5 years, sales grew about 85% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-89.9%
- PassDebt under half of equityNot relying on borrowed money.0.06x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-17.0%
- MissProfitable every yearSteady profits, not one good year.0 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$178K
- MissShare count not growingNot diluting owners. Falling means buybacks.+115.0% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.67.3%
- Revenue
- $2.7M
- +26.3% vs prior year
- 5-year growth
- +84.9%/yr
- revenue, per year
- Total debt
- $91K
- 0.06x equity
- Current ratio
- 1.96x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $847K
- +40.0% YoY
- EPS
- $0.00
- vs $0.00
- Op. margin
- 5.3%
- +3.4 pts
- Gross margin
- 69.6%
- +3.7 pts
- Free cash flow
- -$8K
- Share count
- +104.6%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.5
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Share count growthYearly rate, last 3 years
+17.2%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.0x · $37K debtShares outstandingLatest reported
15MWhy moderate risk- Share count growing 17.2% a year (dilution)
Next reportNot enough history
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.